Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
BASEL, SWITZERLAND: Evolva Holding recently said that it will collaborate with International Flavors & Fragrances Inc for consumer products. The collaboration will be to implement a commercially viable biosynthetic route for the production of a key flavoring ingredient. Under the multi-year agreement, IFF will fund R&D activities at Evolva, focused primarily on the pathway and yield stages of the programme through the scale-up and manufacturing phases. During the collaboration, approximately ten full-time equivalents per year are expected to work on the program. Evolva will receive an upfront technology access fee as well as monthly research fees. IFF will commercialize the resulting product and Evolva will receive a royalty on product sales based on both margin and volume. “After FOSU and Abunda, this is our third collaboration in the food ingredient space within a year. We’re pleased that our synthetic biology platform is being recognized useful to design and optimize production routes for products in health and nutrition,” said Neil Goldsmith, CEO & Managing Director, Evolva. © WOC News
BASEL, SWITZERLAND: Evolva Holding recently said that it will collaborate with International Flavors & Fragrances Inc for consumer products. The collaboration will be to implement a commercially viable biosynthetic route for the production of a key flavoring ingredient.
Under the multi-year agreement, IFF will fund R&D activities at Evolva, focused primarily on the pathway and yield stages of the programme through the scale-up and manufacturing phases. During the collaboration, approximately ten full-time equivalents per year are expected to work on the program. Evolva will receive an upfront technology access fee as well as monthly research fees. IFF will commercialize the resulting product and Evolva will receive a royalty on product sales based on both margin and volume.
“After FOSU and Abunda, this is our third collaboration in the food ingredient space within a year. We’re pleased that our synthetic biology platform is being recognized useful to design and optimize production routes for products in health and nutrition,” said Neil Goldsmith, CEO & Managing Director, Evolva.
© WOC News
Login
Breakthrough step-up in profitability in 2010 Growth strategy well underway PARIS, FRANCE: Rhodia plans far-reaching transformation to ...
KAISERAUGST, SWITZERLAND: DSM has opened its first animal nutrition & health premix plant in India. The new facility allows the company to direc ...
TOKYO, JAPAN: Mitsubishi Gas Chemical will boost its production capacity of polyacetal in Thailand from 55,000 mt/year to 100,000 mt/year by the end o ...
BEIJING, CHINA: China, on Wednesday, banned imports of some food products and additives from Taiwan after authorities in Taipei warned they were taint ...
A new discovery about how molecules are broken down by the body, which will help pharmaceutical chemists design better drugs, has been made by re ...
Existing fibre-reinforced polymer composites are known for their high strength and stiffness, which are used in applications from sporting goods to ...
Stay updated with the latest chemical industry trends and innovations.